Dephosphorylation of tau protein by calcineurin triturated into neural living cells |
| |
Authors: | Wei Qun Holzer Max Brueckner Martina K Liu Yu Arendt Thomas |
| |
Affiliation: | (1) Department of Biochemistry and Molecular Biology, Beijing Normal University, Beijing, People's Republic of China;(2) Paul Flechsig Institute of Brain Research, University of Leipsig, Germany |
| |
Abstract: | Alzheimer disease and related dementia are characterized by the presence of hyperphosphorylated tau aggregated into filaments. The role of tau phosphorylation in the fibrillogenesis has not yet been unraveled. Therefore, it is important to know which phosphatases can dephosphorylate tau protein in vivo. The effect of recombinant purified calcineurin (CN(PP2B)) and several calcineurin mutants on tau phosphorylation was studied in two neuronal like cell lines PC12 and SH-SY5Y. The modulation of tau phosphorylation at Ser199/Ser202, Ser396/Ser404, Ser262/Ser356, and Thr181 sites was examined in these cell lines using the phosphorylation state-dependent antitau antibodies Tau 1, PHF1, 12E8, and AT270. The results have shown that CN directly dephosphorylates all of those sites of tau protein. Recombinant calcineurin introduced into cells that have previously been treated with okadaic acid and cyclosporin A, which are inhibitors of phosphatases (PP1/PP2A and PP2B), has a direct effect on the phosphorylation status on all phosphorylation sites studied. We conclude that calcineurin is (besides PP2A) a important modulator of tau phosphorylation in vivo. |
| |
Keywords: | calcineurin tau protein dephosphorylation Alzheimer's disease PC12 SH-SY5Y |
本文献已被 PubMed SpringerLink 等数据库收录! |
|